Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.250
+0.040 (3.31%)
At close: Feb 21, 2025, 4:00 PM
1.230
-0.020 (-1.60%)
After-hours: Feb 21, 2025, 6:27 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.55 million as of February 21, 2025. Its market cap has increased by 60.18% in one year.
Market Cap
2.55M
Enterprise Value
-3.59M
1-Year Change
60.18%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.55M, a decrease of -95.56%. That is a compound annual growth rate of -58.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.55M | -7.41% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |